Delivery Order SPE2DB22D2214-SPE2DB25FS6HH
Award Date 8/27/25
Potential Completion Date 8/28/25
Potential Value $7.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in syringe form (0.5mL) with a ceiling value of $1,064.40. This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract utilizes no set-aside designation and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $7,836.90 to AmerisourceBergen Drug Corp for Boostrix Tdap vaccine in 0.5ml syringe format. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 18, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Boostrix Tdap vaccine syringes (0.5mL) valued at $1,863.95, with an ultimate completion date of July 30, 2025. This competitive award uses firm fixed pricing with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $52,873.75 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This firm fixed-price, competitively awarded delivery order has an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,342.46 for Boostrix TDAP vaccine in 0.5mL syringe format on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,923.03 to AmerisourceBergen Drug Corp for the supply of Boostrix Tdap Vaccine in 0.5mL syringes. This competitively awarded, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order represents a task order issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,050.38 to supply Boostrix Tdap vaccine in 0.5 mL syringes, with completion targeted for September 15, 2025. This competitively awarded, firm fixed price delivery order represents a small-value transaction under AmerisourceBergen's broader pharmaceutical supply relationships with the federal government. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,064.40 for Boostrix TDAP vaccine in 0.5ml syringes, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's critical role in supporting federal medical procurement, particularly for...
- The Defense Logistics Agency (DLA) awarded a $10,910.10 delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5 mL syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 24, 2025, performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order was competitively awarded and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply framework with the federal government. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Boostrix TDAP vaccine in 0.5ML syringes. This competitively awarded, non-set-aside contract carries a ceiling value of $1,865.25 with a firm fixed price structure and an ultimate completion date of September 2, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a transactional...